reports hero background
Updated: Sep 25, 2026
ETRA Logo

Electra Therapeutics

NASDAQ:ETRA·Stock Analysis Report
Day Range
$11.71 - $13.56
Market Cap
734.37M
P/E Ratio
0.0000
Avg Value
$13.79
Year Range
$13.11 - $14.48
$11.82-$0.85 (-6.71%)
1
General Information
Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer.

Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer.

2
Electra Therapeutics (ETRA) Stock Graph
3
How We Grade Electra Therapeutics (ETRA)

We grade stocks based on past performance, their future growth potential, intrinsic value, dividend history, and overall financial health.

The chart below shows how we grade Electra Therapeutics (ETRA) across the board compared to its closest peers.

4
Benzinga Edge Rankings

Benzinga Edge stock rankings give you four critical scores to help you identify the strongest and weakest stocks to buy and sell.